Kaletra 50 mg/1

Kaletra 50 mg/1 is a combination of lopinavir and ritonavir, used to manage HIV infection. This oral medication is designed to support antiviral therapy, helping to control the virus in the body.

Kaletra 50 mg/1 is primarily used as part of antiretroviral therapy to treat HIV infection. It works by reducing the amount of HIV in the body, which helps to improve immune function and lower the risk of HIV-related complications. This medication is often prescribed in combination with other HIV drugs to enhance effectiveness.

Common effects of Kaletra 50 mg/1 may include nausea, diarrhea, and headache. Some individuals might experience changes in taste, vomiting, or abdominal pain. These effects vary and are not experienced by everyone taking the medication.

Kaletra 50 mg/1 should be handled with care, especially for individuals with liver or kidney problems. It is important to follow the advice of a healthcare provider regarding its use. Pregnant or breastfeeding women should consult a healthcare professional before taking this medication.

Kaletra 50 mg/1 may interact with other medications, including those metabolized by the liver's cytochrome P450 system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.